Table 1 Characteristics of the 193 HCC patients.
Age (years, mean ± SD) | 62.8 ± 11.5 |
Male gender, n (%) | 144 (74.6) |
BMI (kg/m2, mean ± SD) | 24.9 ± 4.4 |
AST (IU/L, mean ± SD) | 56 ± 38 |
ALT (IU/L, mean ± SD) | 51 ± 40 |
α-fetoprotein >20 ng/mL, n (%) | 83 (43.0) |
Fibrosis stage 3–4, n (%) | 104 (53.9) |
HBV/HCV/B + C/NBNC/unknown, n | 87/51/7/37/11 |
Child-Pugh score A, n (%) | 163 (84.5) |
MICA rs2596542 A allele, n (%)* | 90 (46.6) |
BCLC stage 0-A, n (%) | 117 (60.6) |
TMN stage 1-2, n (%) | 159 (82.4) |
Tumor size >5 cm, n (%) | 70 (36.3) |
Tumor number >2, n (%) | 32 (16.6) |
Poor differentiated HCC, n (%)† | 48 (40.3) |